Diabetic Retinopathy and Ocular Melanoma: How far we are?

Diabetic retinopathy causes vascular damage to retinal neurons, presenting characteristics of chronic inflammation. The development of new therapies capable of combating vision loss involves knowledge of inflammatory retinal changes. Studies in animal models and patients with diabetes have shown a h...

Descripción completa

Detalles Bibliográficos
Autores: Souto, Eliana B., Campos, Joana R., Da Ana, Raquel, Fangueiro, Joana F., Martins-Gomes, Carlos, Durazzo, Alessandra, Lucarini, Massimo, Sánchez-López, E. (Elena), Espina García, Marta, García López, María Luisa, Silva, Amélia M., Mendonça, Fernando, Santini, Antonello, Souto, Selma B.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/166560
Acceso en línea:https://hdl.handle.net/2445/166560
Access Level:acceso abierto
Palabra clave:Angiogènesi
Factor de creixement de l'endoteli vascular
Retinopatia diabètica
Melanoma
Ceguesa
Neovascularization
Vascular endothelial growth factors
Diabetic retinopathy
Blindness
Descripción
Sumario:Diabetic retinopathy causes vascular damage to retinal neurons, presenting characteristics of chronic inflammation. The development of new therapies capable of combating vision loss involves knowledge of inflammatory retinal changes. Studies in animal models and patients with diabetes have shown a high expression of the inflammatory molecules that are involved in the progression of diabetic retinopathy. Uveal melanoma is an eye tumour that remains highly deadly, because despite the correct treatment, it still causes metastasis in about 50% of patients. This type of tumour has the ability to produce and store melanin, which may result in resistance to therapy. Over time there has been development of new therapies for this disease, such as radiotherapy and surgical resection. In this review, we discuss diabetic retinopathy and ocular melanoma, their relationship with angiogenesis and the current anti-angiogenic therapies for their treatment